-
USPTO Issues Patent for COM701, Anti-PD-1 Antibody Use
americanpharmaceuticalreview
July 17, 2019
Compugen announced the United States Patent and Trademark Office (USPTO) has granted a new patent covering method of use of COM701, a first-in-class therapeutic antibody targeting PVRIG, in combination with anti-PD-1 antibodies.
-
Velabs Therapeutics Announces €3 Million Series B Financing to Advance its Functional Antibody Screening Programme
b3cnewswire
June 28, 2019
Velabs Therapeutics Announces €3 Million Series B Financing to Advance its Functional Antibody Screening Programme.
-
Researchers discover antibody that interacts with norovirus strains
pharmaceutical-technology
June 20, 2019
Norovirus is a serious stomach virus responsible for 200,000 deaths a year globally. Credit: Centre for Disease Control and Prevention.
-
Genmab, Janssen Partner for Next-Gen CD38 Antibody
contractpharma
June 20, 2019
To collaborate on HexaBody-CD38, a next-generation CD38 antibody product incorporating Genmab's HexaBody technology.
-
Genmab and Janssen Biotech to develop CD38 antibody
pharmaceutical-technology
June 14, 2019
Genmab has signed a global licence and option agreement with Janssen Biotech for the development and commercialisation of a human CD38 monoclonal antibody (mAb).
-
Cantargia, Patheon Biologics Sign Supply Agreement
contractpharma
May 21, 2019
Secures production of antibody CAN04 for clinical trials.
-
Daiichi Sankyo Announces [Fam-] Trastuzumab Deruxtecan Demonstrated Clinically Meaningful Response in Patients with Refractory HER2 Positive Metastatic Breast Cancer, a Population with High Unmet Need
prnewswire
May 08, 2019
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca announced positive topline results for the pivotal phase 2 DESTINY-Breast01 trial of [fam-] trastuzumab deruxtecan (DS-8201).
-
Velabs Therapeutics to Cooperate with Chiome Bioscience in the Field of GPCR-Specific Functional Antibody Screening
b3cnewswire
April 25, 2019
Velabs Therapeutics to Cooperate with Chiome Bioscience in the Field of GPCR-Specific Functional Antibody Screening.
-
Aduro Biotech Appoints CMO
contractpharma
April 23, 2019
Nuyten brings expertise as a radiation oncologist specializing in cancer biology...
-
Technique to identify charge distribution on biomolecules
europeanpharmaceuticalreview
April 22, 2019
A research team has identified a method to analyse biomolecules and their inhomogeneous charge distributions with carbon nanotube thin film transistors…